세계의 오렌시아 아바타셉트 시장 보고서(2025년)

Orencia Abatacept Drug Global Market Report 2025

US $ 4,490 ￦ 6,242,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,023,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,803,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

오렌시아 아바타셉트 의약품 시장 규모는 향후 몇 년 동안 높은 성장세를 보일 것으로 예상됩니다. 예측 기간의 성장은 치료 적응증 확대, 병용 치료 채택 증가, 의료 접근성 향상, 유리한 환급 정책, 새로운 응용 분야를 탐색하는 진행 중인 임상 시험, 고급 치료 옵션에 대한 환자 인식 증가에 기인할 수 있습니다. 이 기간 동안 예상되는 주요 트렌드에는 제형 개선, 피하 전달 방법의 발전, 모니터링을 위한 디지털 헬스 솔루션의 통합, 치료 적응증 확대, 임상시험의 진전 등이 있습니다.

자가면역 질환의 발병률 증가는 향후 오렌시아(아바타셉트) 의약품 시장의 확장을 견인할 것으로 예상됩니다. 자가면역 질환은 면역 체계가 신체의 건강한 세포와 조직을 잘못 공격할 때 발생합니다. 유전적 소인, 환경적 영향, 생활 습관 변화 등 여러 요인이 이러한 질병의 유병률 증가에 기여합니다. 오렌시아(아바타셉트)는 T세포 활성화를 선택적으로 조절하고 염증을 줄이며 관절 손상을 예방하여 자가면역질환 환자를 돕습니다. 이는 질병 관리를 지원하고 삶의 질을 향상시키며 류마티스 관절염 및 건선성 관절염과 같은 질환에 대한 다른 면역 억제 치료제에 대한 의존도를 줄여줍니다. 예를 들어, 2024년 11월 독일에 본사를 둔 기관인 Versorgungsatlas.de는 202년에 7,324만 1,305명의 보험 가입자 중 630만 4,340명이 하나의 자가 면역 질환 진단을 받아 8.61%의 원시 유병률을 기록했다고 보고했습니다. 결과적으로 자가면역질환의 유병률 증가는 오렌시아(아바타셉트) 의약품 시장의 성장을 촉진하고 있습니다.

개인 맞춤형 의약품의 부상은 오렌시아(아바타셉트) 의약품 시장 확대에 더욱 기여하고 있습니다. 개인 맞춤 의학은 개인의 유전적 구성, 환경 및 생활 방식에 따라 치료 및 건강 관리 전략을 맞춤화하여 보다 정확하고 효과적인 결과를 보장하는 접근 방식입니다. 맞춤 의학의 채택이 증가하는 이유는 게놈 기술의 발전, 분자 생물학에 대한 깊은 이해, 정밀 진단 도구의 가용성 증가, 부작용을 최소화하면서 환자 치료 결과를 개선하는 표적 치료법에 대한 수요 때문입니다. 오렌시아(아바타셉트)는 T세포 활성화를 특별히 조절하는 표적 면역 치료을 제공하여 의료진이 질병의 중증도, 환자 프로필, 치료에 대한 개별 반응에 따라 치료 계획을 맞춤화할 수 있도록 함으로써 개인 맞춤형 의학을 지원합니다. 예를 들어, 2023년에 미국을 대표하는 단체인 맞춤 의약품 연합은 2022년에 FDA가 신약의 34%에 대해 맞춤 의약품을 승인했으며, 지난 8년간 신약 승인 중 최소 25%가 맞춤 의약품에 기인한다고 보고했습니다. 따라서 개인 맞춤형 의약품의 채택이 증가함에 따라 오렌시아(아바타셉트)에 대한 수요도 증가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 오렌시아 아바타셉트 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 오렌시아 아바타셉트 시장 : 성장률 분석
• 세계의 오렌시아 아바타셉트 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 오렌시아 아바타셉트 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 오렌시아 아바타셉트 총 시장 규모(TAM)

제6장 시장 세분화

• 세계의 오렌시아 아바타셉트 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 피하 주사
• 정맥 내 주입
• 세계의 오렌시아 아바타셉트 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 류마티스 관절
• 청소년 특발성 관절염
• 건선성 관절염
• 기타 용도
• 세계의 오렌시아 아바타셉트 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 기타 유통 채널
• 세계의 오렌시아 아바타셉트 시장 : 화학 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 고용량 화학 치료 유발성 구강 점막염
• 표준용량 화학 치료 유발성 구강점막염
• 세계의 오렌시아 아바타셉트 시장 : 방사선 치료 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 두경부암의 방사선 치료 유발성 구강 점막염
• 전신 방사선 유발성 구강 점막염
• 세계의 오렌시아 아바타셉트 시장 : 조혈 줄기세포 이식 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 자가 줄기 세포 이식 유발성 구강 점막염
• 동종 줄기세포 이식 유발성 구강점막염

제7장 지역별 및 국가별 분석

• 세계의 오렌시아 아바타셉트 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 오렌시아 아바타셉트 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 오렌시아 아바타셉트 시장 : 경쟁 구도
• 오렌시아 아바타셉트 시장 : 기업 프로파일
  • Bristol-Myers Squibb Company 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 세계 시장 경쟁 벤치마킹과 대시보드

제32장 주요 인수합병(M&A)

제33장 최근 시장 동향

제34장 시장의 잠재력이 높은 국가, 부문, 전략

• 오렌시아 아바타셉트 시장(2029년) : 새로운 기회를 제공하는 국가
• 오렌시아 아바타셉트 시장(2029년) : 새로운 기회를 제공하는 부문
• 오렌시아 아바타셉트 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제35장 부록

HBR

영문 목차

영문목차

Orencia (abatacept) is a biologic drug prescribed for autoimmune disorders that works by inhibiting the activation of T-cells. As a selective co-stimulation modulator, it helps reduce immune system overactivity, thereby lowering inflammation and protecting joints from damage.

The primary product types in the Orencia (abatacept) drug market include subcutaneous injections and intravenous infusions. A subcutaneous injection involves administering the medication into the tissue just beneath the skin using a needle. This drug is used for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and others. It is distributed through multiple channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and other distribution networks.

The orencia abatacept drug market research report is one of a series of new reports from The Business Research Company that provides orencia abatacept drug market statistics, including the orencia abatacept drug industry's global market size, regional shares, competitors with a orencia abatacept drug market share, detailed orencia abatacept drug market segments, market trends and opportunities, and any further data you may need to thrive in the orencia abatacept drug industry. This orencia abatacept drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orencia abatacept drug market size has grown strongly in recent years. It will grow from $3.71 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to the increasing prevalence of autoimmune diseases, rising awareness of biologic therapies, expanding indications for abatacept, growing healthcare expenditure, supportive regulatory approvals, and enhanced market penetration through strategic collaborations.

The orencia abatacept drug market size is expected to see strong growth in the next few years. It will grow to $5.10 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to expanding therapeutic indications, the rising adoption of combination therapies, increased access to healthcare, favorable reimbursement policies, ongoing clinical trials exploring novel applications, and growing patient awareness of advanced treatment options. Key trends expected during this period include improved formulation, advancements in subcutaneous delivery methods, the integration of digital health solutions for monitoring, expanded therapeutic indications, and progress in clinical trials.

The growing incidence of autoimmune diseases is expected to drive the expansion of the Orencia (abatacept) drug market in the coming years. Autoimmune diseases arise when the immune system mistakenly attacks the body's own healthy cells and tissues. Several factors contribute to the increasing prevalence of these diseases, including genetic predisposition, environmental influences, and lifestyle changes. Orencia (abatacept) helps patients with autoimmune disorders by selectively modulating T-cell activation, reducing inflammation, and preventing joint damage. This supports disease management, enhances quality of life, and reduces reliance on other immunosuppressive treatments for conditions such as rheumatoid arthritis and psoriatic arthritis. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. As a result, the increasing prevalence of autoimmune diseases is fueling the growth of the Orencia (abatacept) drug market.

The rise of personalized medicine is further contributing to the expansion of the Orencia (abatacept) drug market. Personalized medicine is an approach that customizes treatment and healthcare strategies based on an individual's genetic makeup, environment, and lifestyle, ensuring more precise and effective outcomes. The growing adoption of personalized medicine is driven by advancements in genomic technologies, a deeper understanding of molecular biology, the increased availability of precision diagnostic tools, and the demand for targeted therapies that enhance patient outcomes while minimizing side effects. Orencia (abatacept) supports personalized medicine by providing targeted immunotherapy that specifically modulates T-cell activation, allowing healthcare providers to tailor treatment plans based on disease severity, patient profiles, and individual responses to therapy. For example, in 2023, the Personalized Medicine Coalition, a US-based representative organization, reported that in 2022, the FDA approved personalized medicines for 34% of new drugs, with at least 25% of new drug approvals in each of the previous eight years attributed to personalized medicine. Consequently, the growing adoption of personalized medicine is driving the demand for Orencia (abatacept).

In January 2023, Lotte Biologics Co. Ltd., a South Korea-based biotechnology company, acquired a biopharmaceutical production facility in New York from Bristol Myers Squibb Company for $160 million. This acquisition is aimed at expanding Lotte Biologics' manufacturing capabilities and strengthening its contract development and manufacturing organization (CDMO) services. Bristol Myers Squibb Company, a US-based pharmaceutical company, specializes in developing biopharmaceutical products, including Orencia (abatacept).

The key player in the orencia abatacept drug market is Bristol-Myers Squibb Company.

North America was the largest region in the orencia abatacept drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in orencia abatacept drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the orencia abatacept drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The orencia abatacept drug consists of sales of monotherapy and combination therapy. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orencia Abatacept Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orencia abatacept drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orencia abatacept drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orencia abatacept drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Subcutaneous Injection; Intravenous Infusion
• 2) By Application: Rheumatoid Arthritis; Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Other Applications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Subsegments:
• 1) By Chemotherapy: High-Dose Chemotherapy-Induced Oral Mucositis; Standard-Dose Chemotherapy-Induced Oral Mucositis
• 2) By Radiotherapy: Head And Neck Cancer Radiotherapy-Induced Oral Mucositis; Total Body Irradiation-Induced Oral Mucositis
• 3) By Hematopoietic Stem Cell Transplantation: Autologous Stem Cell Transplantation-Induced Oral Mucositis; Allogeneic Stem Cell Transplantation-Induced Oral Mucositis
• Companies Mentioned: Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Orencia Abatacept Drug Market Characteristics

3. Orencia Abatacept Drug Market Trends And Strategies

4. Orencia Abatacept Drug Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Orencia Abatacept Drug Growth Analysis And Strategic Analysis Framework

• 5.1. Global Orencia Abatacept Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Orencia Abatacept Drug Market Growth Rate Analysis
• 5.4. Global Orencia Abatacept Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Orencia Abatacept Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Orencia Abatacept Drug Total Addressable Market (TAM)

6. Orencia Abatacept Drug Market Segmentation

• 6.1. Global Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subcutaneous Injection
• Intravenous Infusion
• 6.2. Global Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rheumatoid Arthritis
• Juvenile Idiopathic Arthritis
• Psoriatic Arthritis
• Other Applications
• 6.3. Global Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Orencia Abatacept Drug Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Dose Chemotherapy-Induced Oral Mucositis
• Standard-Dose Chemotherapy-Induced Oral Mucositis
• 6.5. Global Orencia Abatacept Drug Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Head And Neck Cancer Radiotherapy-Induced Oral Mucositis
• Total Body Irradiation-Induced Oral Mucositis
• 6.6. Global Orencia Abatacept Drug Market, Sub-Segmentation Of Hematopoietic Stem Cell Transplantation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Stem Cell Transplantation-Induced Oral Mucositis
• Allogeneic Stem Cell Transplantation-Induced Oral Mucositis

7. Orencia Abatacept Drug Market Regional And Country Analysis

• 7.1. Global Orencia Abatacept Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Orencia Abatacept Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Orencia Abatacept Drug Market

• 8.1. Asia-Pacific Orencia Abatacept Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Orencia Abatacept Drug Market

• 9.1. China Orencia Abatacept Drug Market Overview
• 9.2. China Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Orencia Abatacept Drug Market

• 10.1. India Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Orencia Abatacept Drug Market

• 11.1. Japan Orencia Abatacept Drug Market Overview
• 11.2. Japan Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Orencia Abatacept Drug Market

• 12.1. Australia Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Orencia Abatacept Drug Market

• 13.1. Indonesia Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Orencia Abatacept Drug Market

• 14.1. South Korea Orencia Abatacept Drug Market Overview
• 14.2. South Korea Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Orencia Abatacept Drug Market

• 15.1. Western Europe Orencia Abatacept Drug Market Overview
• 15.2. Western Europe Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Orencia Abatacept Drug Market

• 16.1. UK Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Orencia Abatacept Drug Market

• 17.1. Germany Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Orencia Abatacept Drug Market

• 18.1. France Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Orencia Abatacept Drug Market

• 19.1. Italy Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Orencia Abatacept Drug Market

• 20.1. Spain Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Orencia Abatacept Drug Market

• 21.1. Eastern Europe Orencia Abatacept Drug Market Overview
• 21.2. Eastern Europe Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Orencia Abatacept Drug Market

• 22.1. Russia Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Orencia Abatacept Drug Market

• 23.1. North America Orencia Abatacept Drug Market Overview
• 23.2. North America Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Orencia Abatacept Drug Market

• 24.1. USA Orencia Abatacept Drug Market Overview
• 24.2. USA Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Orencia Abatacept Drug Market

• 25.1. Canada Orencia Abatacept Drug Market Overview
• 25.2. Canada Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Orencia Abatacept Drug Market

• 26.1. South America Orencia Abatacept Drug Market Overview
• 26.2. South America Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Orencia Abatacept Drug Market

• 27.1. Brazil Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Orencia Abatacept Drug Market

• 28.1. Middle East Orencia Abatacept Drug Market Overview
• 28.2. Middle East Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Orencia Abatacept Drug Market

• 29.1. Africa Orencia Abatacept Drug Market Overview
• 29.2. Africa Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Orencia Abatacept Drug Market Competitive Landscape And Company Profiles

• 30.1. Orencia Abatacept Drug Market Competitive Landscape
• 30.2. Orencia Abatacept Drug Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Global Orencia Abatacept Drug Market Competitive Benchmarking And Dashboard

32. Key Mergers And Acquisitions In The Orencia Abatacept Drug Market

33. Recent Developments In The Orencia Abatacept Drug Market

34. Orencia Abatacept Drug Market High Potential Countries, Segments and Strategies

• 34.1 Orencia Abatacept Drug Market In 2029 - Countries Offering Most New Opportunities
• 34.2 Orencia Abatacept Drug Market In 2029 - Segments Offering Most New Opportunities
• 34.3 Orencia Abatacept Drug Market In 2029 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer

관련자료